Catalent Formulation Expert to Present at the 4th Annual Improving Solubility Conference
Somerset, NJ, March 25, 2010 — Jeffrey E. Browne, Ph.D. Technical Director, Pharmaceutical Softgel Business Development, Catalent Pharma Solutions, will be presenting at the 4th Annual Improving Solubility Conference on March 29-30, 2010 in Philadelphia, PA.
Dr. Browne’s presentation, “How to Enhance the Bioavailability of Poorly Soluble Compounds Using Lipid-Based Formulations” will take place on Wednesday, March 31, 2010 at 9:15 AM. The presentation focuses on designing strategies for the successful development of lipid-based formulations giving due consideration to the formulation’s digestibility and dispersibility. The discussion will also examine the mechanism by which these two important formulation considerations enhance absorption. Dr. Browne will also present case studies that illustrate the importance of digestion and dispersion.
For more information or to register for the conference, visit: http://www.improvingsolubility.com/Event.aspx?id=221616 .
For more information on Catalent’s softgel technologies, go to: http://www.catalent.com/softgel75 .
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,100 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit www.catalent.com .